Tag Archives: anti-dermatitis

NanoActive Phloretin

Posted on by

Advanced Nano-Delivery System for Enhanced Bioavailability & Skin Penetration

1.PRODUCT DESCRIPTION

NanoActive Phloretin is a highly advanced, water-dispersible nano-structured delivery system developed specifically for high-end cosmetic and dermatological formulations. Phloretin, a natural dihydrochalcone polyphenol primarily extracted from the root bark of apple trees (Malus domestica), possesses extraordinary biological properties including potent tyrosinase inhibition, broad-spectrum free radical scavenging, anti-inflammatory effects, and cellular DNA protection.

Despite its remarkable therapeutic potential, raw crystalline Phloretin faces significant formulation constraints in personal care applications due to its severe lipophilicity, poor aqueous solubility, susceptibility to oxidation, and limited capacity to cross the thermodynamic barrier of the stratum corneum. PuriPharm overcomes these challenges by utilizing an innovative multi-lamellar liposomal architecture. By encapsulating Phloretin into nanostructured lipid matrices (Particle Size < 50 nm), the system dramatically amplifies active molecule stability, optimizes delivery kinetics, and increases biological skin absorption without the use of irritating organic solvents or high alcohol levels.

2.TECHNICAL SPECIFICATIONS

3. BIOLOGICAL EFFICACY & MECHANISMS

3.1 Advanced Melanin Regulation & Skin Whitening

NanoActive Phloretin acts as a highly effective inhibitor of mammalian tyrosinase, the rate-limiting enzyme in melanogenesis. It downregulates the conversion of L-tyrosine to L-DOPA, suppressing melanin synthesis at a cellular level. Clinical data exhibits an ultra-low half-maximal inhibitory concentration (IC50 = 37.5 μmol/L), significantly outperforming traditional agents like Kojic Acid and Arbutin. The nano-delivery system ensures active transport into basal layer melanocytes, effectively fading post-inflammatory hyperpigmentation (PIH), evening out skin tone, and enhancing overall skin translucency and L* luminosity values.

3.2 Comprehensive Antioxidant & Radical Scavenging Architecture

The polyphenolic structure of Phloretin offers powerful electron-donating properties to neutralize destructive reactive oxygen species (ROS). In comparative DPPH radical scavenging assays executed within aqueous environments, standard crystalline Phloretin displays suboptimal performance due to poor phase dispersion. Under identical aqueous test conditions:

Pure Crystalline Phloretin: 42% free radical scavenging capacity.

L-Ascorbic Acid (Vitamin C): 88% free radical scavenging capacity.

NanoActive Phloretin: 94% radical scavenging efficiency.

This distinct upregulation is driven by the amphiphilic lipid membrane shell, which maximizes contact surface area with free radicals in the water phase while preserving the inner molecular integrity of the active polyphenol.

3.3 Sebum Regulation & Anti-Acne Efficacy

NanoActive Phloretin modifies the sebaceous microenvironment through multi-pathway mechanisms. It restricts excessive sebocyte lipogenesis, yielding a quantifiable reductions in sebum output and a long-lasting matte skin finish within 4 weeks. Concurrently, its strong anti-inflammatory properties inhibit Prostaglandin E2 (PGE2) secretion and cyclooxygenase-2 (COX-2) expression, yielding a 29.1% reduction in inflammatory pustules and acne-induced erythema.

3.4 Deep Cellular DNA Shield & Photo-Aging Defense

Beyond traditional cosmetic benefits, NanoActive Phloretin provides genuine biological protection against ultraviolet (UV) irradiation. It enters viable epidermal layers to prevent the formation of cyclobutane pyrimidine dimers (Thymine Dimers) within cellular DNA. It dampens ultraviolet-induced p53 protein expression (a critical cellular stress indicator) and strictly blocks the up-regulation of Matrix Metalloproteinase-9 (MMP-9), thus preventing the structural breakdown of dermal collagen matrices and mitigating chronic photo-induced aging.

4. FORMULATION & PROCESSING GUIDELINES

Formulator’s Edge: Unlike conventional crystalline Phloretin which is prone to recrystallization, sedimentation, and sudden color shifts, NanoActive Phloretin features excellent structural stability and effortless integration into diverse cosmetic chassis.

Recommended Use Level: 0.5% – 2.0% depending on the targeted performance profile (e.g., intensive whitening vs. daily antioxidant defense).

Optimal Formulation pH: Safe and stable across a broad pH span of 3.0 to 6.5. Optimum shelf stability is achieved between pH 4.5 and 6.5.

Processing Temperature: Cold processable. The product should preferably be incorporated during the final phase of manufacturing (cool-down stage) at temperatures below 45°C.

Incorporation Technique: Directly add to the aqueous phase under gentle stirring. Compatible with surfactant systems, hydrogels, O/W emulsions, and clear transparent serums without inducing recrystallization.

5. STORAGE, PACKAGING & SHELF LIFE

  • Packaging: Available in 1 kg, 5 kg, and 25 kg food-grade, UV-shielded polyethylene containers.
  • Storage Conditions: Store in the original sealed container at temperatures between 2°C and 25°C (refrigerated storage recommended for maximum lifecycle shelf-life). Keep away from direct sunlight, moisture, and localized heat sources.
  • Shelf Life: 12 months from the date of manufacture when stored strictly in compliance with recommended conditions.

6. REGULATORY & SAFETY PROFILE

Safety Assessment: Non-irritating to human skin (0.0% irritation index in patch testing). Non-phototoxic, non-sensitizing, and free from genetically modified organisms (GMO-free).

Compliance: INCI registered components. Globally compliant with EU, US FDA, and China NMPA safety technical standards for cosmetics.

Product Introduction: PuriActives® Ceramide E

Posted on by

Product Introduction: PuriActives® Ceramide E

Advanced Biomimetic Lipid for Intensive Skin Barrier Restoration

1. Executive Overview: The Next Generation of Dermocosmetics

PuriActives® Ceramide E (INCI: Cetyl-PG Hydroxyethyl Palmitamide) represents a breakthrough in biomimetic lipid technology. Engineered specifically for the premium skincare and clinical dermocosmetics market, this high-purity pseudo-ceramide precisely replicates the structural geometry and biological function of human Ceramide Type 2.

By acting as the ultimate “intercellular cement,” it effectively fortifies the stratum corneum, restoring the skin’s primary defense system against modern environmental stressors.

2. The Science of Biomimicry: Mechanism of Action

Natural ceramides are easily depleted by aging, harsh surfactants, and environmental factors, leading to compromised skin barriers (e.g., Atopic Dermatitis, extreme dryness).

PuriActives® Ceramide E resolves this through advanced structural homology:

  • Intercalation: Its optimized molecular weight and lipophilic tail allow it to seamlessly intercalate into the existing lipid matrix of the skin.
  • TEWL Reduction: It physically seals the micro-fissures in the stratum corneum, dramatically reducing Transepidermal Water Loss (TEWL) and locking in endogenous moisture.
  • Barrier Reinforcement: Protects sensitive nerve endings from external irritants, instantly soothing reactive skin.

3. The Thermodynamic Advantage: Lamellar Phases

Beyond mere occlusion, PuriActives® Ceramide E is distinguished by its thermodynamic behavior in cosmetic formulations.

When co-emulsified with physiological lipids (cholesterol and free fatty acids), it self-assembles into highly ordered Liquid Crystalline Lamellar Phases.

  • Sustained Release: This multi-layered structure mimics healthy human sebum, offering long-lasting, sustained hydration rather than a temporary surface coating.
  • Elegant Skin-Feel: It delivers rich, intensive moisturization without the heavy, greasy tackiness traditionally associated with heavy ointments.

4. Formulation Excellence: The “Golden Ratio”

To unlock the maximum clinical efficacy of PuriActives® Ceramide E, our scientists recommend the biomimetic 3:1:1 Ratio (Ceramide : Cholesterol : Free Fatty Acid).

Application Versatility:

  • Face & Body Care: Barrier repair creams, anti-aging moisturizers, and soothing lotions for sensitive/eczema-prone skin (Use Level: 0.1% – 3.0%).
  • Advanced Hair Care: Deep conditioning masks and post-chemical treatment (bleaching/coloring) cuticle lipid replenishment.
  • Baby Care: Ultra-gentle, skin-identical protection for developing skin barriers.

5. Premium Quality & “Clean Label” Promise

Manufactured under the rigorous quality control standards of PuriPharm, this ingredient is designed for formulators targeting the “Clean Beauty” and high-end clinical segments.

  • 100% Preservative & Antioxidant Free: Eliminates the risk of sensitization from additive chemicals.
  • Exceptional Purity: Heavy metals meticulously controlled (≤10mg/kg), ensuring safety for the most sensitive dermatological applications.
  • Microbiological Superiority: Meets and exceeds stringent pharmacopeial-grade limits (Aerobic Plate Count ≤1000 CFU/g).
  • Proven Stability: Guaranteed shelf life of 36 months at room temperature (4~25℃), demonstrating robust chemical stability.

PuriPharm Co., Ltd. – Innovating at the intersection of biotechnology and dermatological science. Contact our technical team for custom formulation guidance and clinical data dossiers.

NanoActive® BAICALIN: The Intelligent “Telomerase” Activator for Cellular Youth

Posted on by

Unleashing Baicalin’s Cellular Anti-Aging Potential through Advanced Nano-Targeted Delivery

1. Discovering Nature’s Time Code: Baicalin & The Delivery Bottleneck

Scutellaria baicalensis Georgi has long been revered as a “Golden Herb” in traditional Eastern medicine. Its core polyphenolic flavonoid active—Baicalin—has been extensively validated by top-tier SCI journals (e.g., Journal of Investigative Dermatology, Free Radical Biology and Medicine) for its outstanding pharmacological properties, including ROS scavenging, MMPs inhibition, and broad-spectrum UV protection.

However, in modern dermatology and premium cosmetic applications, unmodified Baicalin faces a notoriously difficult translational gap: stellarin vitrodata, but mediocrein vivoefficacy. This is driven by three critical challenges:

  • High Crystallinity & Poor Solubility: Highly prone to crystallization and precipitation in cosmetic emulsions or serums, making it impossible to maintain at high free-state concentrations.
  • Extreme Physicochemical Instability: Containing multiple oxidation-prone phenolic hydroxyl groups, it easily browns and develops off-odors when exposed to light, heat, or mildly alkaline formulations.
  • Extremely Low Bioavailability: Its large molecular polarity means it is heavily blocked by the dense “brick-and-mortar” structure of the Stratum Corneum, failing to penetrate into the dermis to exert gene-level targeted effects.

PuriPharm: The NanoActive® Targeted Intelligent Delivery Solution

Fusing biomimetic medicine with nanofluidic dynamics, PuriPharm utilizes its proprietary NanoActive® encapsulation technology. We have constructed Multilamellar Vesicles that highly mimic the structure of human cell membranes, precisely and stably embedding high-purity Baicalin within an amphiphilic nano-bilayer structure.

This breakthrough technology completely dismantles Baicalin’s physical barriers, achieving a systemic quadruple leap: High Solubility, Supreme Stability, Targeted Deep Penetration, and Prolonged Sustained Release.

2. Core Mechanism of Action (MoA): Targeting the Root of Cellular Senescence

Leveraging the highly efficient transmembrane fusion capabilities of the NanoActive® carrier, Baicalin can reach efficacious therapeutic concentrations inside living cells, exerting critical regulatory roles across three cutting-edge anti-aging pathways:

2.1 Targeted Telomerase Activation, Guarding the DNA Terminal Lifeline

Nobel Prize-winning research indicates that replicative cellular senescence is dictated by the “biological clocks” at the ends of chromosomes—Telomeres. UV irradiation and chronic oxidative stress dramatically accelerate telomere shortening, leading to irreversible cellular senescence.

  • Upregulation of TERT Genes: NanoActive® BAICALIN penetrates deep into the nucleus to specifically activate or maintain the expression levels of Telomerase Reverse Transcriptase (TERT).
  • Rescuing G1 Phase Arrest: It significantly downregulates core senescence switch genes p53 and p16INK4a (induced by DNA damage), enabling dormant senescent cells to regain their capacity for division and self-renewal, effectively turning back the clock at the genetic level.

2.2 Reversing SASP (Senescence-Associated Secretory Phenotype) — Cellular “Senomorphics”

In modern anti-aging medicine, clearing or modifying the toxic factors secreted by senescent cells (SASP, e.g., IL-6, IL-8, MMPs) is the most sought-after strategy.

NanoActive® BAICALIN demonstrates potent “Senomorphic” activity. It strongly inhibits the NF-κB inflammatory signaling pathway, severing the contagious cascade of SASP that destroys the surrounding healthy Extracellular Matrix (ECM), thereby protecting the Type I and Type III collagen networks.

2.3 Awakening the Nrf2/ARE Antioxidant Master Switch

Transcending the limitations of traditional antioxidants (like Vitamin C and E) which consume themselves in a 1:1 ratio with free radicals, NanoActive® BAICALIN acts as an “ignition key” for the cell’s endogenous defense mechanisms. By dissociating the Keap1-Nrf2 complex, it promotes Nrf2 nuclear translocation and binding to the ARE sequence, exponentially amplifying the expression of endogenous antioxidant enzymes (SOD, CAT, GSH-Px).

3. Outstanding Scientific Efficacy: Defining Anti-Aging Limits with Data

3.1 Nano-Targeted Delivery & Kinetics

Experiment A: HaCaT Cellular Internalization

Assessed using fluorescent probes (Coumarin-6) combined with flow cytometry and confocal microscopy.

●Results: After a 2-hour incubation, the absolute intracellular fluorescence intensity of the NanoActive® group was 4.2 times higher than that of the unencapsulated free Baicalin group. The biomimetic liposomes seamlessly fused via endocytosis, achieving highly efficient “targeted airdrops.”

Experiment B: Franz Diffusion Cell & Higuchi Release Model

●Penetration: The cumulative amount of Baicalin penetrating the porcine ear epidermis into the receptor fluid over 24 hours was 8.5 times greater for NanoActive® BAICALIN compared to standard Baicalin raw materials.

●Release Profile: The release curve perfectly aligns with the Higuchi Diffusion Equation (R² > 0.98), exhibiting characteristic matrix-type sustained release. It delivers a steady release over 24 hours, avoiding the “peak and valley” effect of drug concentration to ensure long-lasting, gentle, and effective results.

3.2 In Vitro & 3D Ex Vivo Skin Models

Experiment C: Fibroblast Telomerase Activity Protection (TRAP Assay)

Human primary fibroblasts were exposed to a UVA photo-damage model.

●Results: UVA reduced fibroblast telomerase activity to 31.2% of the normal group. Following pretreatment with NanoActive® BAICALIN, telomerase activity recovered to 63.9%, confirming its direct protective effect on the TERT mechanism.

Experiment D: 3D Full-Thickness Skin Model Remodeling

Continuous topical application of the test substance on a reconstructed 3D skin model for 7 days.

●Results: H&E staining and immunofluorescence of tissue sections showed that, compared to the control group, the NanoActive® BAICALIN treated group exhibited a 17% increase in epidermal thickness, a 145% enhancement in the fluorescence expression intensity of Pro-collagen I in the dermis, and a significantly denser and more undulated Dermal-Epidermal Junction (DEJ) architecture.

3.3 In Vivo Clinical Efficacy

●Study Design: A randomized, double-blind, placebo-controlled clinical trial. 35 female subjects aged 35-55 with moderate photoaging and wrinkles applied a base cream containing 2% NanoActive® BAICALIN to half of their face twice daily for 56 days. Instrumental evaluations included VISIA®-CR, Cutometer®, and high-frequency skin ultrasound.

Core Clinical Data:

  1. Leap in Dermal Density (Skin Density via Ultrasound): Evaluated using a 20 MHz high-frequency ultrasound scan. After 56 days of use, the dermal density significantly increased by 19.3% (measured by the reduction of the Subepidermal Low Echogenic Band, SLEB), proving substantial remodeling of the collagen network.
  2. Deep Wrinkle Reduction & Smoothing: Maximum depth of crow’s feet wrinkles (Rz) was reduced by 22.4%, and skin roughness (Ra) decreased by 16.5%.
  3. Potent Soothing & Anti-Inflammaging (Erythema Index): The skin Erythema Index showed a significant drop as early as day 14 (-11%), with a cumulative reduction of 18% over 56 days, clinically validating its soothing efficacy against micro-inflammation induced by SASP.

4. Technical Advantages & Formulation Guidelines

NanoActive® BAICALIN is a “plug-and-play” bioactive designed for high-end skincare products pursuing ultimate clinical efficacy.

  • INCI Name: Scutellaria Baicalensis Root Extract
  • Appearance: Light yellow to brownish-yellow translucent nano-fluid.
  • Particle Size: 10-100nm (DLS detection, PDI < 0.2). This ultra-small particle size is the core of its transparent appearance and deep transdermal penetration.
  • Superior Formulation Compatibility:
  • Disperses perfectly in the aqueous phase; zero crystallization or precipitation over time.
  • Broad pH tolerance range (pH 4.0 – 7.5).
  • Ease of Use: Cold processable; can be added directly to the water phase. For hot emulsion systems, addition is recommended during the cooling phase post-homogenization (< 45°C).

●Extreme Stability Challenge: Under accelerated testing for 3 months at 40°C and 5000 Lux illumination, the active retention rate of Baicalin in NanoActive® BAICALIN was> 95%, with zero browning and zero off-odors (Note: unencapsulated Baicalin severely degrades and discolors within 15 days under identical conditions).

Market Positioning & Applications (Claims):

  • Recommended Dosage: Daily maintenance and early anti-aging (0.5% – 2.0%); Targeted telomerase activation, intensive anti-wrinkle, and photo-damage repair (2.0% – 5.0%).
  • Marketing Claims: Telomerase Guardian, Cellular Longevity Extension, Senolytics/Senomorphics, Photoaging Reversal, Non-Destructive Deep Delivery.
  • Applicable Formats: Premium anti-aging creams, gene-repair base serums, high-potency antioxidant sunscreens, post-microneedling/laser wound-healing serums, luxury scalp anti-aging and anti-hair-loss tonics.

NanoActive® BAICALIN— The underlying engine for international cutting-edge cellular skincare.

Researched and Manufactured by PuriPharm. Fusing macromolecular delivery kinetics with systems biomedicine to rewrite time and unlock the secrets of ageless skin.

NanoActive r-RETINOATE

Posted on by

NanoActive r-RETINOATE

8× retinol activity

Photostable • Non-irritating

A next-generation vitamin A derivative

Company Overview

PuriPharm Biopharmaceutical Technology Co., Ltd.

Delivering Beauty • Creating Value

Focused on the research and development of bioactives.

  • Specialized in the development of bioactive materials and functional ingredient systems.
  • Combines scientific delivery technology with application-oriented product design.
  • Dedicated to high-performance ingredients for beauty and personal care.

Nano Delivery Technology

  • One of the most widely studied and applied new formulation technologies.
  • Applicable across pharmaceuticals, foods, cosmetics and other fields.
  • Nano-bioactives are new products developed using nanodelivery systems.
  • Improves solubility, stability, irritation profile and odor while offering unique biological effects.

Fourth-Generation (4G) Cosmetic Ingredients

  • Clearly defined ingredients and content
  • Clearly defined targets
  • Clear mechanism of action
  • Formulations designed to preserve bioactivity
  • Good solubility
  • Stable and non-discoloring
  • Easy to absorb

A perfect combination of traditional medicine, modern biotechnology and nanotechnology.

Unique Occlusion Effect

Follicular Targeted Absorption

  • Nanocarriers accumulate efficiently around the hair follicle pathway.
  • This supports targeted delivery into deep skin appendages where actives can be retained and released.

Key takeaway：Hair follicles provide an efficient access route for targeted nano-delivery.

Smaller Particles Penetrate Deeper

and in Greater Amounts

  • Reduced particle size increases penetration depth in skin.
  • Smaller particles also increase the delivered amount of active ingredient.

The smaller the carrier, the deeper the penetration and the higher the delivery amount.

Follicular Reservoir Enables Slow Release for

More Than 10 Days

  • Hair follicles act as a storage reservoir for the active ingredient.
  • The active can be released gradually for more than 10 days after deposition.
  • This supports long-lasting efficacy with sustained local availability.

Long-lasting delivery：Slow release extends the activity window after follicular deposition.

Vitamin A：

A core scientific foundation for the product story

Functions of Vitamin A in the Human Body

  • Supports vision and visual signaling.
  • Contributes to growth, reproduction and immune support.
  • Involved in antioxidant defense, cell differentiation and gene transcription.

Vitamin A and Nobel Prizes

Vitamin A Is the Gold Standard in Anti-Aging Skincare

Common Vitamin A Actives Used in Skincare

Conversion to Retinoic Acid in Vivo

Why It Won the Award

2019 Ringier Technology Innovation Award

  • Vitamin A derivative suitable for daytime use
  • Safe and low irritation
  • Nano-encapsulation protects the active ingredient
  • A breakthrough and a new technical approach for retinoid raw materials

A distinctive retinoid concept that balances efficacy, stability and tolerability.

Unique Absorption Spectrum

  • Distinctive absorption profile
  • Efficient blue-light absorption
  • Good photostability

Product Introduction

  • Retinyl retinoate is obtained by esterifying the hydroxyl group of retinol with retinoic acid, while avoiding the application limits of retinol and retinoic acid in cosmetics.
  • NanoActive r-RETINOATE has an encapsulated particle size of 20–30 nm. This nanoemulsion size keeps the active stably suspended in the nanocarrier, enhances skin penetration and helps control the release rate.

Particle size：20–30 nm nano-encapsulation；

Delivery effect：Stable suspension, enhanced penetration and controlled release

Product Introduction

Skincare Benefits of Retinyl Retinoate

Efficacy Summary

Product Description

Formulation Guide

Suitable Products

Anti-aging products：

Maintains collagen in the dermis and helps prevent excessive collagen degradation.

When combined with hyaluronic acid and biocomposite polysaccharides (hydrolyzed myrtle), improvement in fine lines can be observed within one week.

Brightening products：

Works synergistically with vitamin C to inhibit tyrosinase, promote metabolism and accelerate fading of melanin.

The source deck notes that pairing with vitamin C is also effective for acne-prone skin.

Suitable Products

Sunscreen products：

Inhibits the UV-induced increase of MMP activity and helps protect elastic fibers and dermal collagen.

Improves wrinkles and fine lines caused by UV exposure.

Repair products：

Promotes endogenous hyaluronic acid synthesis and reduces skin TEWL.

Promotes keratinocyte activity and increases epidermal thickness, making the epidermis stronger.

NanoActive® 7-DHC THE SKIN-NATIVE PROVITAMIN D PLATFORM

Posted on by
Executive Overview
Science-Backed Innovation
PuriPharmis a leading specialist in the design and manufacture of high-functional cosmetic active ingredients and advanced delivery platforms.
Our mission is to empower global B2B customers with biologically meaningful solutions that translate complex cellular science into commercially successful skincare products.
PuriPharmBrand Framework
Why 7-DHC Matters
Endogenous Relevance
7-dehydrocholesterol (7-DHC) is a skin-native precursor produced naturally in the human epidermis.
As a key intermediate in the cholesterol biosynthetic pathway, it represents a truebiomimeticapproach to skin health, aligning with the skin’s inherent chemistry.
 
The Provitamin D Pathway
Homeostatic Skin Support
Translating Science to Beauty
The Delivery Advantage
The 7-DHC Innovation Platform
Beyond Traditional Actives
NanoActive® 7-DHC represents more than an ingredient—it is abiological platformfor brands seeking the next frontier in skin resilience.
By mimicking endogenous pathways, it offers a “Biology-First” marketing angle that resonates with sophisticated, research-driven consumers.
Mechanism of Action
Evidence Hierarchy
Polished Claim Map
Formulation Guidelines
Concept Applications
Target Consumer Needs
 
The Differentiation Edge
Commercial Strategic Value
Key Takeaways
 

Retinal (Retinaldehyde) Market Outlook & Strategic Analysis Report

Posted on by

I. Background:

The “EU Vitamin A Restriction” Shaking the Industry

The formal implementation of Regulation (EU) 2024/996 marks a pivotal regulatory turning point for Vitamin A derivatives in the skincare industry.

1. Key Regulatory Highlights

  • Concentration Thresholds: From November 1, 2025, new face and leave-on products must not exceed 0.3% Retinol Equivalent (RE); body lotions are limited to 0.05% RE.
  • Grace Period: Non-compliant products already on the market must be withdrawn by May 1, 2027.
  • Mandatory Labeling: Products must include a warning: “Contains Vitamin A. Consider your daily intake before use.”

2. Industry Ripple Effects

This regulation forces a paradigm shift from “High Concentration” to “High Efficiency.” Retinal (Retinaldehyde), the direct precursor to Retinoic Acid, has emerged as the premier alternative to Retinol, offering superior performance within the new legal limits.

II. Core Value:

Why Retinal is the “Optimal Solution”

Under the 0.3% concentration cap, Retinal provides a much higher “performance ceiling” compared to Retinol.

  • Conversion Efficiency: Retinal requires only one conversion step to become Retinoic Acid (the active form), whereas Retinol requires two. Research indicates Retinal’s bio-activity is approximately 10-11 times more efficient than Retinol.
  • Compliance Advantage: At the 0.3% EU limit, Retinal can deliver anti-aging results comparable to unregulated high-concentration Retinol (1.0%+) products of the past.
  • Antibacterial Benefits: Unlike Retinol, Retinal possesses natural antimicrobial activity, making it a unique solution for the “adult acne & anti-aging” dual-segment.

III. Technical Strategy:

Advanced Delivery & Synergistic Formulas

To overcome Retinal’s inherent instability, the following next-generation combinations are recommended:

1. Retinal + Silybin (Phyto-Retinol Strategy):

  • Silybin is highlighted as the premier plant-based Retinol alternative. It promotes collagen regeneration via “Retinoid-like” pathways without the irritation.
  • Its potent anti-inflammatory properties significantly down-regulate pro-inflammatory cytokines, mitigating the potential irritation often associated with Retinal.

2. Retinal + Hexylresorcinol (Multi-Target Aging):

  • Hexylresorcinol inhibits melanin synthesis while reinforcing the dermal support structure.
  • This synergy achieves a “1+1>2” effect for intensive wrinkle reduction and skin tone brightening.

IV. Core Competitive Advantages of PuriPharm

As a leader in Nano-Delivery Systems (NDS), PuriPharm is uniquely positioned to solve the stability and penetration challenges of Retinal:

1. Pharmaceutical-Grade Nano-Encapsulation (NanoActive®)

  • Solving Stability Issues: Retinal is extremely sensitive to light and oxygen. PuriPharm’s Nano-Liposome technology isolates the active from environmental factors, ensuring long-term potency.
  • Enhanced Skin Penetration: With particle sizes typically below 30nm, NanoActive® RAL (Retinal) penetrates the skin barrier more effectively than traditional formulations, reaching the deeper dermis.
  • Reduced Irritation (De-noising): Controlled release technology ensures a steady delivery of actives, minimizing the “Retinoid reaction” (redness and peeling).

2. Comprehensive Synergistic Ingredient Portfolio

PuriPharm provides a complete suite of nano-encapsulated actives, including NanoActive® RAL, NanoActive® Silybin, and NanoActive® Hexylresorcinol.

Universal Nano-Compatibility allows formulators to combine these “Triple Threat” ingredients seamlessly, ensuring physical stability and a premium, non-greasy skin feel.

3. Professional R&D & Data Support

  • Backed by a founding team with deep pharmaceutical backgrounds, PuriPharm provides robust in-vitro and clinical efficacy data. This assists global brands in justifying their claims and navigating strict EU labeling requirements.

V. Strategic Opportunities for the International Market

  1. Concentration-to-Efficiency Rebranding: Help brands leverage 0.3% Retinal Nano-products to outperform 1.0% Retinol competitors in efficacy.
  2. Global Compliance Transition: Provide ready-to-use, EU-compliant ingredient solutions and stability dossiers for brands looking to enter or stay in the European market.
  3. Custom NDS Development: Utilize the NDS platform to create exclusive “Retinal + X” nano-complexes, building a proprietary technical moat for the brand.

VI. Conclusion

The EU Vitamin A restriction is not an end, but the beginning of the “Era of Scientific Anti-Aging.” By utilizing PuriPharm’s Nano-Delivery Systems to master the stability and delivery of Retinal, brands can achieve market dominance in the post-retinol landscape.

Bioactive HD 100

Posted on by

Hexamidine diisethionate；HD-100；BioActive HD 100；Elestab HP 100.

anti-dandruff; anti-acne; anti-dermatitis; deodorizing; stratum corneum repair; skin anti-aging.

CAS: 659-40-5.

Continue reading→